From: Genomic characterization of remission in juvenile idiopathic arthritis
Training group | |||||||
---|---|---|---|---|---|---|---|
Response to methotrexate | Response to methotrexate + etanercept | Healthy control | |||||
Patients | Age | Time to CRM | Patients | Age | Time to CRM | Control | Age |
 |  | (month) |  | (month) |  |  |  |
1 | 9 | 7 | 1 | 13 | 20 | 1 | 16 |
2 | 16 | 8 | 2 | 3 | 24 | 2 | 18 |
3* | 11 | 10 | 3 | 3 | 48 | 3 | 9 |
4 | 7 | 14 | 4 | 6 | 8 | 4 | 11 |
5 | 11 | 12 | 5 | 4 | 18 | 5 | 10 |
6* | 6 | 15 | 6 | 5 | 42 | 6 | 11 |
7 | 7 | 32 | 7 | 14 | 15 | 7 | 10 |
8* | 11 | 13 | 8 | 9 | 25 | 8 | 10 |
9 | 7 | 36 | 9 | 10 | 30 | 9 | 11 |
10 | 4 | 46 | 10 | 15 | 25 | 10 | 13 |
11 | 11 | 8 | 11 | 11 | 20 | 11 | 13 |
12 | 7 | 15 | 12 | 12 | 24 | 12 | 10 |
13 | 11 | 48 | 13 | 12 | 24 | 13 | 12 |
14* | 6 | 9 | 14 | 7 | 11 | 14 | 12 |
Testing group | |||||||
Response to methotrexate | Response to methotrexate + etanercept | Healthy control | |||||
Patients | Age | Time to CRM | Patients | Age | Time to CRM | Control | Age |
 | (month) |  |  |  | (month) |  |  |
1 | 12 | 27 | 1 | 9 | 24 | 1 | 12 |
2 | 5 | 12 | 2 | 17 | 10 | 2 | 15 |
3 | 12 | 11 | 3 | 6 | 17 | 3 | 8 |
4 | 14 | 11 | 4 | 7 | 26 | 4 | 9 |
5 | 16 | 11 | 5 | 12 | 26 | 5 | 8 |
6 | 5 | 13 | 6 | 5 | 18 | 6 | 11 |
7 | 4 | 10 | 7 | 6 | 24 | 7 | 15 |
8 | 7 | 17 | 8 | 15 | 16 | 8 | 11 |